Related Experiment Videos
Long chain polyunsaturated fatty acid levels in chronic illness
The Journal of Family Health Care
|March 13, 2003
Summary
Abnormal long chain polyunsaturated fatty acid (LCP) levels are linked to chronic diseases in children. Supplementation may be an effective treatment for these conditions.
Area of Science:
- Biochemistry
- Pediatrics
- Nutrition Science
Background:
- Abnormal long chain polyunsaturated fatty acid (LCP) levels are observed in pediatric chronic diseases.
- Dietary restrictions or metabolic pathway abnormalities can cause these LCP imbalances.
- LCP supplementation has shown efficacy in certain cases.
Purpose of the Study:
- To review studies on LCP levels in children with chronic diseases.
- To assess the effectiveness of LCP supplementation in this population.
Main Methods:
- Literature review of studies examining LCP levels.
- Analysis of studies reporting on LCP supplementation outcomes in pediatric chronic diseases.
Main Results:
- Studies indicate a correlation between chronic diseases and altered LCP levels in children.
- Evidence suggests LCP supplementation can be beneficial for some children with chronic conditions.
Conclusions:
- Managing LCP levels is important in pediatric chronic disease management.
- Further research into LCP supplementation protocols for specific chronic conditions is warranted.